Han Han, Ph.D. - Publications

2013 Pharmaceutical Sciences University of Southern California, Los Angeles, CA, United States 
DNA methylation, cancer, epigenetics

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Cheng R, Jiang N, Yang X, Xue D, Liu S, Han H. The influence of geological movements on the population differentiation of Biston panterinaria (Lepidoptera: Geometridae) Journal of Biogeography. 43: 691-702. DOI: 10.1111/jbi.12676  0.56
2015 Cao J, Zhang X, Wang Q, Qiu G, Hou C, Wang J, Cheng Q, Lan Y, Han H, Shen H, Zhang Y, Yang X, Shen B, Zhang J. Smad4 represses the generation of memory-precursor effector T cells but is required for the differentiation of central memory T cells. Cell Death & Disease. 6: e1984. PMID 26583325 DOI: 10.1038/cddis.2015.337  0.56
2015 Xu B, Jiang C, Han H, Liu H, Tang M, Liu L, Ji W, Lu X, Yang X, Zhang Y, Liu Y. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signaling. Clinical and Experimental Pharmacology & Physiology. PMID 26356761 DOI: 10.1111/1440-1681.12488  0.56
2015 Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, O'Brien C, De Carvalho DD. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. Cell. 162: 961-73. PMID 26317465 DOI: 10.1016/j.cell.2015.07.056  0.56
2014 Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 26: 577-90. PMID 25263941 DOI: 10.1016/j.ccr.2014.07.028  0.56
2013 Han H, Yang X, Pandiyan K, Liang G. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells. Plos One. 8: e75136. PMID 24040395 DOI: 10.1371/journal.pone.0075136  0.56
2012 Han H, Wolff EM, Liang G. Epigenetic alterations in bladder cancer and their potential clinical implications. Advances in Urology. 2012: 546917. PMID 22829811 DOI: 10.1155/2012/546917  0.56
2012 Yang X, Noushmehr H, Han H, Andreu-Vieyra C, Liang G, Jones PA. Gene reactivation by 5-aza-2'-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. Plos Genetics. 8: e1002604. PMID 22479200 DOI: 10.1371/journal.pgen.1002604  0.56
2012 Sharma S, Gerke DS, Han HF, Jeong S, Stallcup MR, Jones PA, Liang G. Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells. Epigenetics & Chromatin. 5: 3. PMID 22284370 DOI: 10.1186/1756-8935-5-3  0.32
2011 Han H, Cortez CC, Yang X, Nichols PW, Jones PA, Liang G. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Human Molecular Genetics. 20: 4299-310. PMID 21835883 DOI: 10.1093/hmg/ddr356  0.56
2010 Yang X, Lay F, Han H, Jones PA. Targeting DNA methylation for epigenetic therapy. Trends in Pharmacological Sciences. 31: 536-46. PMID 20846732 DOI: 10.1016/j.tips.2010.08.001  0.56
2010 Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. Plos Genetics. 6: e1000917. PMID 20421991 DOI: 10.1371/journal.pgen.1000917  0.4
2009 Jeong S, Liang G, Sharma S, Lin JC, Choi SH, Han H, Yoo CB, Egger G, Yang AS, Jones PA. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Molecular and Cellular Biology. 29: 5366-76. PMID 19620278 DOI: 10.1128/MCB.00484-09  0.56
Show low-probability matches.